REQUEST A DEMO
Total
USD $0.00
Search more companies

Hunan Hansen Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hunan Hansen Pharmaceutical Co., Ltd. Profile Updated: April 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

This is a pharmaceutical manufacturer focusing on research, production and sales, which is the high-tech enterprises in Hunan Province and key pharmaceutical industrial enterprise of Hunan Province . The main production in Western medicine, with a large volume injection, small volume injection, oral liquid, tablets, capsules, granules, syrup, decoction agents, tinctures, pills, etc. 10 formulations, have all passed the GMP certification. Company currently has a total of 129 species, 186 drug production specifications approval number. Simotang oral solution is a quick rule out gastrointestinal toxins, fully enhanced digestive function of the conditioning effects prescription for the exclusive patent products, and won the "Hunan high-tech products", "Hunan brand" and "Hunan Product Quality Award "; Ginkgo biloba capsules as the National Development and Reform Commission issued" competitive prices "products; reduced spring capsule of Chinese medicine for the country to protect species.

Headquarters
No. 2688, Yincheng Avenue, Heshan District, Yiyang City, Hunan Province
Yiyang; Hunan; Postal Code: 413000

Contact Details: Purchase the Hunan Hansen Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.hansenzy.com

Basic Information
Total Employees:
Purchase the Hunan Hansen Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Hunan Hansen Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Hunan Hansen Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Hunan Hansen Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
January 21, 1998
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Representative of Securities Affairs
Ownership Details
Purchase this report to view the information.
42.13%
Purchase this report to view the information.
4.82%
Purchase this report to view the information.
1.49%
Purchase this report to view the information.
1.42%
Purchase this report to view the information.
1.11%
Subsidiaries
Changsha Sanyin Real Estate Development Co., Ltd.
Hansen Health Industry (Hunan) Co., Ltd.
Hunan Hansen Pharmaceutical Research Co., Ltd.
Company Performance
Financial values in the chart are available after Hunan Hansen Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
1.54%
Total operating revenue
-1.83%
Operating profit (EBIT)
8.45%
EBITDA
8.41%
Net Profit (Loss) for the Period
5.81%
Total assets
0.91%
Total equity
3.72%
Operating Profit Margin (ROS)
1.7%
Net Profit Margin
0.93%
Return on Equity (ROE)
0.05%
Debt to Equity Ratio
-1.46%
Quick Ratio
0.37%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?